Skip to main content
OpenTrials
Completed

NCT Number: NCT02925754

Catastrophism Among Chronic Pain Patients in Rheumatology

Pain catastrophizing is conceptualized as a negative cognitive-affective response to anticipated or actual pain and has been associated with a number of important pain-related outcomes.

The aims of this study are

1. To describe the characteristics of the patients and determinants of catastrophizing in chronic painful patients hospitalized in rheumatology in the Nîmes University Hospital 2. To describe the impact of the catastrophizing on the level of insomnia and the drugs consumption in chronic painful patients hospitalized in rheumatology in the Nîmes University Hospital

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nîmes

Nîmes, 30029, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults hospitalized in the department of rheumatology of the Nîmes University Hospital with chronic pain (≥ 6 months)

Exclusion criteria

  • benzodiazepine or neuroleptic use for epilepsia, alcool, psychiatric disorders
  • Restless Legs syndrom
  • Obstructive Sleep Apnea
  • narcolepsy

Treatment and study plan

Primary outcomes

  1. Pain Catastrophizing Scale

    Time frame: Day 0

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Oct 6, 2016
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.